Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Basket Trial of Pembrolizumab in Patients With Advanced Solid Tumors and Genomic Instability

NCT03428802 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT03428802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03428802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Basket Trial of Pembrolizumab in Patients With Advanced Solid Tumors and Genomic Instability
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 8, 2018
Completion date
September 21, 2027
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 gene mutation, brca2 gene mutation, locally advanced solid neoplasm, metastatic malignant solid neoplasm, pold1 gene mutation, pole gene mutation, recurrent malignant solid neoplasm, recurrent ovarian carcinoma, stage iii breast cancer ajcc v7, stage iii ovarian cancer ajcc v8, stage iiia breast cancer ajcc v7, stage iiia ovarian cancer ajcc v8, stage iiib breast cancer ajcc v7, stage iiib ovarian cancer ajcc v8, stage iiic breast cancer ajcc v7, stage iiic ovarian cancer ajcc v8, stage iv breast cancer ajcc v6 and v7, stage iv ovarian cancer ajcc v8, stage iva ovarian cancer ajcc v8, stage ivb ovarian cancer ajcc v8